Several reports have indicated the presence of thyrotropin (TSH) receptors in fat tissues (Teng et al. 1975 ; Davies et al. 1978; Gill et al. 1978a, b ; Trokoudes et al. 1979 ; Kishihara et al. 1979a Kishihara et al. , b, 1981 . TSH receptors on thyroid membranes appear to be important in the pathogenesis of Graves' disease, since sera of these patients contain antibodies which interact with TSH recepors and may cause hyperthyroidism (Smith and Hall 1974; Smith et al. 1985) . These antibodies also inhibit TSH binding to fat cell membranes (Teng et al. 1975 ; Kishihara et al. 1979a Kishihara et al. , 1981 . Recent reports have demonstrated that antibodies in the serum of patients with Graves' disease appeared to bind to membranes with TSH receptors (Tao and Kriss 1982 ; Baker et al. 1983) . It is beneficial to use fat cell membranes to detect these antibodies owing to the lack of confusion caused by the presence of antithyroid antibodies other than TSH receptor antibodies (TRAb). Properties of TSH binding to guinea pig fat membranes have been reported in detail from other laboratories (Teng et al. 1975 ; Gill et al. 1978a , b ; Kishihara et al. 1979a Kishihara et al. , b, 1981 . TSH binding to human fat membranes was reported to be highly sensitive to normal immunoglobulin G (IgG) (Gill et al. 1980) . However, few studies about TSH binding to rat fat membranes were reported (Gill et al. 1978a ). Kishihara et al. (1979a) reported that TSH receptors could not be detected on rat fat membranes. In the present report, the presence of TSH receptors on rat fat membranes was confirmed, and their interaction with TSH and Graves' IgG was compared with that of human thyroid membranes.
MATERIALS AND METHODS

Preparation of rat fat and human thyroid membrane
Rat fat membranes were prepared from the epididymal fat pads and perinephric fat tissues of male Sprague-Dawley rats using the method of Teng et al. (1975) with minor modifications. Briefly, fat tissues were razor-minced and homogenized by a Polytron homogenizes in 10 volumes of homogenizing buffer (250 mM sucrose, 1 mM EDTA, 20 mM Tris-HC1, pH 7.4). A particulate fraction containing plasma membranes (800 to 10,000 x g) obtained from 1 g wet tissue was suspended in 0.2 ml of 20 mM Tris-HCl at pH 7.4 containing 1 mM EDTA, and stored at -80°C.
Human thyroid membranes, obtained from 1 g wet tissue of Graves' thyroid and prepared as described above, were suspended in 1 ml of the buffer and stored at -80°C until use.
Iodination of bTSH
Highly purified bovine TSH (bTSH) (generous gift from Dr. J.G. Pierce, UCLA, Los Angles, CA, USA and Dr. N. Ui, Gunma University, Maebashi) was labeled with 125I (New England Nuclear Corp., Boston, MA, USA) by the lactoperoxidase method to yield a specific activity of 50 to 80,uCi/,ug. Then labeled TSH was purified using human thyroid membranes and sephadex G100 column chromatography according to the method of Smith and Hall (1974) . The bindings of these two purified bTSH preparations to human thyroid membranes were almost identical (data were not shown).
Preparation of IgG
Serum IgG fractions were prepared from sera of 12 patients with Graves' disease and 3 normal subjects by precipitation with ammonium sulfate (a final concentration of 1.6 M). The fractions were dissolved in distilled water, dialyzed against 50 mM NaCI, 10 mM Tris-HC1, pH 7.4, at 4°C for 24 hr, adjusted to the concentration of 10 mg ml, and stored at -20 °C. Protein concentrations were determined by the method of Lowry et al. (1951) using bovine serum albumin as the standard.
bTSH binding assay Standard binding conditions were as follows. Rat fat membranes in 501ul buffer were incubated with unlabeled bTSH (Thytropa n, Armour Pharmaceutical Co., Chicago, IL, USA) or Graves' IgG in 100,u1 of assay buffer (50 mM NaCI, 0.1% BSA, 10 mM Tris-HCI, pH 7.4) at 37°C for 10 min. Then 100,u1 of labeled TSH (10,000 cpm) was added and the incubation was continued at 4°C for further 2 hr. Fat membranes were sedimented by a Beckmann Microfuge at 10,000 X g at 4°C for 5 min and the radioactivity of the pellets was counted with a gamma counter (Model AL-201, Shimadzu Seisakusho LTD, Tokyo). Results were corrected by subtracting the nonspecific binding. The binding studies of human thyroid membranes were carried out as previously described by Smith and Hall (1974) . Fat membranes were present at the concentration of 22 to 30pg protein/tube, and human thyroid membranes were present at the concentration of 70 to 100 p g protein/tube. The effects of sulfhydryl (SH) reagents on TSH binding to rat fat membranes were examined as follows. Rat fat or human thyroid membranes were incubated with 10 mM dithiotheitol (DTT) or 1 mM azodicarboxylic acid-bis-dimethylamide (diamide) at 37°C for 45 min and washed two times with incubation buffer. Then standard binding assay was carried out. The effect of IgG from the patients with Graves' disease on TSH bindinbg to rat fat and human thyroid membranes was expressed as thyrotropin binding inhibitor immunoglobulin (TBII) index [TBII index (%)=(specific binding of labeled TSH in the presence of patient's IgG/specific binding of labeled TSH in the presence of control IgG) x 100] .
Statistical analysis
Statistical analysis was done by Student's t-test.
RESULTS
The time course of TSH binding to rat fat membranes is shown in Fig. 1 . At 37°C, its binding was rapid, reaching the maximal level in 15 min, followed by a marked fall during the next 2 hr. At 4°C, the binding was slow, but reached a steady state after 2 hr and remained unchanged up to 24 hr. The incubation of labeled TSH in subsequent experiments was therefore carried out for 2 hr at 4°C.
In the absence of unlabeled TSH, incubation time before the addition of labeled TSH was prolonged up to 45 min at 37°C, but no reduction of the binding was observed. Labeled TSH binding to human thyroid membranes reached the maximal level in 30 min at 37°C and unchanged for 2 hr. Specific binding to rat fat membranes was 25 to 31% and that to human thyroid membranes was 14 to 24%.
The concentration of 50 mM of NaCI significantly inhibited the specific binding to rat fat membranes whereas the same concentration of NaCI did not inhibit the binding to human thyroid membranes (Fig. 2) . TSH binding to rat fat membranes was almost completely inhibited by 150 mM NaCI although the binding to human thyroid membranes was reduced by 40%.
TSH binding to rat fat membranes was not affected by SH reagents although the binding to the thyroid membranes was affected significantly by 102 M DTT Fig. 2 . Effect of NaCI concentrations on labeled TSH binding to rat fat and human thyroid membranes. Rat fat membranes (.) were incubated with labeled TSH at 4°C for 2 hr and human thyroid membranes (o) were incubated with labeled TSR at 37°C for an hour. Each point represents the mean of duplicate determinations. (Table 1) . Up to a concentration of 0.025 mg membrane protein/tube, TSH binding to rat fat membranes linearly increased along with the increase of protein concentra- Fig. 3 . The concentration of TSH was calculated based on a molecular weight of 28,000 and a biological activity of 40IU/mg for highly purified TSH. Rat fat membranes (., -), human thyroid membranes (` , --).
tions. As shown in Fig. 3 , the binding to rat fat membranes was inhibited by unlabeled TSH in a dose-dependent manner. Conventional Scatchard analysis of this result gave a linear relationship and indicated the presence of a single class of high affinity TSH binding sites on rat fat membranes (Fig. 4) . Table 2 shows the binding characteristics of rat fat and human thyroid membranes. Rat fat membranes possessed a lower affinity constant (Ka) of 2.6 x 108 M-1 and larger binding capacity per mg membrane protein (31.2 x 10-s mole) than a high affinity binding site of human thyroid membranes (9.3 x 108 M-1 and 1.2 x 10-s mole), although the yield of human thyroid membrane fraction from 1 g wet tissue was 10 times greater than that of rat fat membrane fraction. Graves' IgG inhibited TSH binding to rat fat membranes. A good correlation was observed between TBII index obtained with these two membrane preparations (Fig. 5) . Normal IgG markedly reduced TSH binding to rat fat 
DISCUSSION
Specific binding sites for TSH have been shown to exist on the membranes prepared from rat fat tissues. TSH binding to rat fat membranes was noticeably rapid and unstable at 3TC, unlike the binding to human thyroid membranes. This result was also different from those on TSH binding to guinea pig fat membranes prepared with an identical differential centrifugation process (Teng et al. 1975 ; Kishihara et al. 1979a ).
The concentration of 50 mM of NaCI significantly inhibited the binding to rat fat membranes whereas the same concentration of NaCI did not inhibit TSH binding to human thyroid membranes. Gill et al. (1978a, b) reported that TSH binding to guinea pig and human fat membranes was considerably reduced under such conditions. These results may suggest that TSH binding to fat membranes is highly sensitive to the presence of NaCI. At present it is not clear whether the decrease in TSH binding to rat fat membranes observed with prolonged incubation after the addition of labeled TSH at 37°C and the presence of NaCI was due to factors such as the release of receptors from the membranes or changes in the receptor environment leading to altered kinetic characteristics.
Triton X100 solubilized guinea pig fat membranes showed the same susceptibility to temperature (Kishihara et al. 1981) , and in the present study the preincub ation of rat fat membranes at 37°C for 45 min did not reduce TSH binding to rat fat membranes. These results probably suggest that the receptors in rat fat tissue are more susceptible to changes in the receptor environment than those in human thyroid gland. Susceptibility to these changes of TSH receptors on rat fat membranes may be a cause for the difficulty in determining TSH receptors on rat fat membranes.
TSH binding to rat fat membranes was not affected by the treatment with DTT or diamide, although Ozawa et al. (1979) and Koizumi et al. (1982) reported that SH reducing reagents decreased TSH binding to thyroid TSH receptors. Recent reports suggested that TSH receptors in human and porcine thyroid gland contained two subunits linked by a disulfide bridge(s) (Koizumi et al. 1982; Islam and Farid 1985; Kajita et al. 1985) and these reagents are thought to change these structures. Kajita et al. (1985) also reported that TSH receptors on guinea pig fat membranes were composed of two subunits. These findings may suggest some structural differences of TSH receptors on rat fat membranes from those on human thyroid membranes (Eggo and Burrow 1982) .
The conventional Scatchard plots obtained from the displacement data showed a single class of high affinity binding site, whereas high and low affinity binding sites were present in human thyroid membranes as previously reported (Manley et al. 1974 ; Marshall et al. 1977 (Gill et al. 1978a (Gill et al. , 1980 Kishihara et al. 1981) or two binding sites (Kishihara et al. 1979a ; Trokoudes et al. 1979 ; Leoffier et al. 1983) for TSH were reported. The reasons for this discrepancy were not clear. The impurity of labeled TSH was thought to be responsible. Kishihara et al. (1981) reported that a single class of binding site for TSH could be observed in guinea pig fat membranes using highly purified labeled bTSH although with relatively crude labeled bTSH two binding sites were detected. On the other hand, Loeffier et al. (1983) reported two binding sites for TSH using highly purified TSH. Other reports suggested that ionic strength of incubation buffer affected TSH binding to thyroid membranes (Powell-Jones et al. 1980; Pekonen and Weintraub 1980) . In the present study we used the same labeled bTSH and incubation buffer to determine the TSH receptors on rat fat membranes, so a single class of binding sites was thought to be specific to rat fat membranes. The value of Ka of rat fat membranes was lower than that of high affinity site of human thyroid membranes, although the values of guinea pig fat membranes were reported to be similar to that of human thyroid membranes (Endo et al. 1981; Loeffier et al. 1983) .
Immunoglobulins from patients with Graves' disease inhibited TSH binding to rat fat membranes as well as that to human thyroid membranes, although normal IgG significantly reduced TSH binding to rat fat membranes. TBII index obtained with these two membrane preparations were significantly correlated. These results suggest that TRAb crossreacts with TSH receptors on rat fat membranes. A significant correlation between the inhibition activities of Graves' IgG on TSH binding to guinea pig fat and human or porcine thyroid membranes was reported (Kishihara et al. 1979b; Parkes et al. 1985) . From these findings it is conceivable that TRAb is not species specific as reported by Davies (1981) and Strakosch et al. (1982) .
In conclusion, TSH has been shown to bind to rat fat membranes. The properties of TSH binding to rat fat membranes were not identical to those of TSH binding to human thyroid membranes. TRAb detected in sera of patients with Graves' disease crossreacted with TSH receptors in rat fat tissue.
